Biolase Inc
BIOL
Market Cap$731.94K
Close$
$1.53
7551.5% upside
Current Fair Value
7551.5% upsideUndervalued by 7551.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $731,942.00 |
|---|---|
| Enterprise Value | $11.18 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-16.14 |
| Beta | 0.68 |
| Outstanding Shares | 33,391,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.08 |
| Price to Sales | 0.02 |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | -0.66 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.41 |
| Debt to Equity | 7.14 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biolase Inc
CEO: Todd Norbe